Joinn Laboratories(China)Co.,Ltd. provided earnings guidance for the period from 1 January 2022 to 30 June 2022. For the period, company expected that the net profit attributable to the shareholders of the Company will increase from approximately RMB 187.2221 million to RMB 248.7161 million as compared with the data in the financial statements for the corresponding period of last year, representing a period-on-period increase of approximately 121.8% to 161.8%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.82 CNY | -2.47% | -6.39% | -33.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.28% | 1.51B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 603127 Stock
- News Joinn Laboratories(China)Co.,Ltd.
- Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Period from 1 January 2022 to 30 June 2022